Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Thursday, November 21, 2019 · 502,832,355 Articles · 3+ Million Readers

Global Blood Stream Infection Testing Market Outlook 2017-2026 - Drivers, Constraints, Opportunities, Threats, Challenges, & Investment Opportunities

/EIN News/ -- Dublin, Feb. 08, 2019 (GLOBE NEWSWIRE) -- The "Blood Stream Infection Testing - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.

Global Blood Stream Infection Testing Market is expected to grow at a CAGR of 8.9% during the forecast period.

Some of the factors such as rise in prevalence of infections such as abdominal infections, dental infections and increase in occurrence geriatric population are fueling the market growth. However, strict government rules associated to the safety and efficacy is limiting the market growth. Blood Stream Infection testing market provides ample opportunities to ongoing R&D activities in various countries across the globe.

Blood stream infection is a condition in which bacterial, fungal, or any infection is detected in the blood. It normally arises when infection in any part of body enters the blood stream and this infection is also considered as blood poisoning, bacteremia, septicemia, or sepsis. Self-diagnosis of blood stream infections is difficult due to its regular symptoms such as chills, fever, diarrhea, vomiting. As a result, testing is mandatory for detection of infection in blood.

Amongst End User, Hospital Laboratories segment accounted held significant market share during the forecast period. The healthcare industry is steadily adopting automated solutions to diminish the cost incurred on staffing and to produce accurate results. Also, automated solutions aid healthcare professionals in reducing the time taken for manually intensive tasks. This allows researchers to focus extensively on patient consultation and precision in diagnosis and improving productivity.

By geography, North America dominated the market during the forecast period due to the factors such as high infection rate, increase in awareness, high diagnosis rate, favorable medical reimbursement scenario, and developed medical facilities in this region.

What our report offers:

  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Key Topics Covered:

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.5 Research Sources

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Blood Stream Infection Testing Market, By Test Type
5.1 Introduction
5.2 Conventional Blood Culture Tests
5.3 Blood Gases
5.4 Complete Blood Count (CBC)
5.5 Culture of Skin Sore
5.6 Cerebrospinal Fluid (CSF) Culture
5.7 Platelet Count
5.8 Urine Culture
5.9 Chest X-Ray
5.10 Clotting Studies
5.10.1 Fibrinogen Levels
5.10.2 Prothrombin Time (PT)
5.10.3 Partial Thromboplastin Time (PTT)
5.11 Polymerase Chain Reaction (PCR) Method
5.12 Nucleic Acid Testing
5.13 Mass Spectroscopy
5.14 Point-of-Care Testing

6 Global Blood Stream Infection Testing Market, By Product
6.1 Introduction
6.2 Reagents
6.3 Instruments
6.4 Other Products

7 Global Blood Stream Infection Testing Market, By Technology
7.1 Introduction
7.2 Non-Conventional Testing
7.3 Conventional Testing

8 Global Blood Stream Infection Testing Market, By Application
8.1 Introduction
8.2 Mycobacteria
8.3 Fungemia
8.4 Bacteremia

9 Global Blood Stream Infection Testing Market, By End User
9.1 Introduction
9.2 Hospital Laboratories
9.3 Reference Laboratories
9.4 Academic Research Laboratories
9.5 Independent Diagnostic Centers
9.6 Other End Users

10 Global Blood Stream Infection Testing Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa

11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling
12.1 Thermo Fisher Scientific Inc.
12.2 Siemens Healthcare
12.3 F. Hoffmann-La Roche Ag.
12.4 Danaher
12.5 Cepheid Inc
12.6 C. R. Bard, Inc.
12.7 Biomrieux Inc.
12.8 Becton, Dickinson And Company
12.9 Beckman Coulter Inc
12.10 Alere Inc.
12.11 Abbott Laboratories

For more information about this report visit https://www.researchandmarkets.com/research/pqsct8/global_blood?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

                    CONTACT: ResearchAndMarkets.com
                             Laura Wood, Senior Press Manager
                             press@researchandmarkets.com
                             For E.S.T Office Hours Call 1-917-300-0470
                             For U.S./CAN Toll Free Call 1-800-526-8630
                             For GMT Office Hours Call +353-1-416-8900
                    Related Topics: Infectious Disease Testing
                    

22157.jpg

Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release